These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 31336)
1. Potentiation of hyperphagia and relief of hypothermia in the genetically obese mouse (genotype, ob/ob) by alpha-methyl tyrosine. Batt RA; Wilson CA; Topping DL Int J Obes; 1978; 2(3):303-7. PubMed ID: 31336 [TBL] [Abstract][Full Text] [Related]
2. Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice. Bailey CJ; Flatt PR; Ewan C Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):233-9. PubMed ID: 3767527 [TBL] [Abstract][Full Text] [Related]
3. Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. Jürgens HS; Schürmann A; Kluge R; Ortmann S; Klaus S; Joost HG; Tschöp MH Physiol Genomics; 2006 Apr; 25(2):234-41. PubMed ID: 16614459 [TBL] [Abstract][Full Text] [Related]
4. Acute effects of nicotine on plasma free fatty acid concentrations and on the response to cold stress, in lean and obese (genotype ob/ob) mice. Batt RA; Topping DL Int J Obes; 1979; 3(1):7-13. PubMed ID: 528120 [TBL] [Abstract][Full Text] [Related]
5. Decreased food intake in response to cholecystokinin (pancreozymin) in wild-type and obese mice (genotype ob/ob). Batt RA Int J Obes; 1983; 7(1):25-9. PubMed ID: 6573302 [TBL] [Abstract][Full Text] [Related]
6. Brown adipose tissue: contributions of nature and nurture to the obesity of an obese mutant mouse (ob/ob). Ashwell M; Wells C; Dunnett SB Int J Obes; 1986; 10(5):355-73. PubMed ID: 3781722 [TBL] [Abstract][Full Text] [Related]
7. Development of the hypothermia in obese mice (genotype ob/ob). Batt RA; Hambi M Int J Obes; 1982; 6(4):391-7. PubMed ID: 7129751 [TBL] [Abstract][Full Text] [Related]
9. Effect of competitive antagonism of NO synthetase on weight and food intake in obese and diabetic mice. Morley JE; Flood JF Am J Physiol; 1994 Jan; 266(1 Pt 2):R164-8. PubMed ID: 7508208 [TBL] [Abstract][Full Text] [Related]
10. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Priestman DA; van der Spoel AC; Butters TD; Dwek RA; Platt FM Diabetes Obes Metab; 2008 Feb; 10(2):159-66. PubMed ID: 18190430 [TBL] [Abstract][Full Text] [Related]
11. The effect of limit feeding on thermogenesis and thermoregulation in genetically obese (ob/ob) mice during cold exposure. Vinter J; Hull D; Batt RA; Tyler DD Int J Obes; 1988; 12(2):111-7. PubMed ID: 3384557 [TBL] [Abstract][Full Text] [Related]
12. Food intake during tumor growth: anorexia in genetically obese ob/ob mice and hyperphagia in lean mice. Thompson CI; Kreider JW; Margules DL Physiol Behav; 1984 Jun; 32(6):935-9. PubMed ID: 6593752 [TBL] [Abstract][Full Text] [Related]
13. Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice. Dubuc PU; Peterson CM J Pharmacol Exp Ther; 1990 Dec; 255(3):976-9. PubMed ID: 2124625 [TBL] [Abstract][Full Text] [Related]
14. Effects of acetylenedicarboxylate: relationship between decreased carcass lipid and increased liver size and lean body weight. Arch JR; Cornish S; Green A; Cawthorne MA Int J Obes; 1979; 3(4):289-99. PubMed ID: 393646 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of dark onset feeding in obese mice (genotype ob/ob) following central injection of norepinephrine and clonidine. Currie PJ; Wilson LM Eur J Pharmacol; 1993 Mar; 232(2-3):227-34. PubMed ID: 8467860 [TBL] [Abstract][Full Text] [Related]
16. Genetically obese (ob/ob) mice are hypersensitive to glucocorticoid stimulation of feeding but dramatically resist glucocorticoid-induced weight loss. McGinnis R; Walker J; Margules D Life Sci; 1987 Apr; 40(16):1561-70. PubMed ID: 3561166 [TBL] [Abstract][Full Text] [Related]
17. [Peripuberal development of genetic obesity in beta rats. Daily changes in food intake, body weight, deep body temperature, triglyceridemia and glycemia]. Calderari S; Gayol MC; Elliff MI; Labourdette V; Troiano MF; Romano G Acta Physiol Pharmacol Latinoam; 1990; 40(4):391-402. PubMed ID: 2101545 [TBL] [Abstract][Full Text] [Related]
18. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice. Irwin N; Montgomery IA; Moffett RC; Flatt PR Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436 [TBL] [Abstract][Full Text] [Related]
19. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice. Bailey CJ; Flatt PR Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872 [TBL] [Abstract][Full Text] [Related]
20. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice. Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]